ArticleInternational journal of transgender health2026
Assessment of breast and prostate cancer risk in trans and gender diverse individuals receiving gender-affirming hormone therapy.
Jiping Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.